Tag: cost, quality & value

Drug rebates often mean consumers pay more for drugs. Manufacturers raise list prices to cover PBM rebates. We pay a percent of list price.

Southcentral Foundation in Alaska provides excellent healthcare for half the money spent on other patients in that state. What can we learn from them?

Richard Migliori MD, EVP & Chief Medical Officer of UnitedHealth Group describes the health care company's multi-pronged response to the COVID-19 pandemic.

Doctors, patients, and insurers can all benefit from improved transparency in payer-provider relationships in areas ranging from costs to care management.

If you are thinking about opening a medical practice, you need to know about these three common challenges and how to overcome them.

New research finds that dementia has a substantial impact on the costs and prevalence of certain common comorbid conditions compared with matched individuals without dementia.

The makers of Learjet collect data & program what is learned about critical system failures in order to improve flight safety. Healthcare should do the same.

America’s healthcare value crisis is rooted in the failure to focus on managing quality. However, some providers have systematically improved quality with outstanding results.

Adding step-therapy to Medicare Advantage Part B drugs can delay access to effective medications putting patients at risk. 3 easy tweaks can mitigate the risk.

A recent study shows that value-based insurance desig reduces consumer cost-sharing for clinically indicated medications and increases adherence without changing total spending.

There's a growing number of providers committed to delivering high-value care & a group of purchasers willing to go around traditional arrangements to access it.

Even as Americans are forced to resign to healthcare costs that have reached an all-time high, it is indisputable that patients continue to pay more while receiving less. Administrative costs related to wasteful bureaucracy is a major contributor.